Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 8, 1998, Pages 1493-1503

  Campo, Giuseppe M ^a   Squadrito, Francesco ^a   Campo, Salvatore ^a   Altavilla, Domenica ^a   Quartarone, Cristina ^a   Ceccarelli, Stefano ^b   Ferlito, Marcella ^a   Avenoso, Angela ^a   Squadrito, Giovanni ^a   Saitta, Antonino ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Biomedica Foscama Research Centre   (Italy)

Author keywords

Antioxidant; Free radicals; Lipid peroxidation; Myocardial ischemia reperfusion injury; Raxofelast; Vitamin E

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL DERIVATIVE; ANTIOXIDANT; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; RAXOFELAST; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART RATE; HEMODYNAMICS; INTRAPERITONEAL DRUG ADMINISTRATION; LEFT CORONARY ARTERY; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE; NEUTROPHIL; NONHUMAN; PEROXIDATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT;

EID: 0032143886     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0713     Document Type: Article

References (45)

1. BINDOLI A, RIGOBELLO MP, MUSACCHIO E, SCURI R, RIZZOLI V, GALZIGNA L, 1991. Protective action of a new benzofuran derivative on lipid peroxidation and sulphydryl groups oxidation. Pharmacol Res 24: 369-375.
2. BUCHWALD A, KLEIN HH, LINDERT S, 1989. Effect of α-tocopherol (vitamin E) in a porcine model of stunned myocardium. J Cardiovasc Pharmacol 14: 46-52.
3. BURTON GW, FOSTER DO, PERLY B, SLATER TF, SMITH ICP, INGOLD KU, 1985. Biological antioxidants. Phil Trans R Soc London B 311: 565-578.
4. CALAPAI G, SQUADRITO F, RIZZO A, CAMPO GM, ALTAVILLA D, CAPUTI AP, 1993. A new antioxidant drug limits brain damage induced by transient cerebrial ischemia. Drugs Exp Clin Res 19: 159-164.
5. CAMPO GM, SQUADRITO F, IOCULANO M, ALTAVILLA D, CALAPAI G, ZINGARELLI B, SCURI R, CAPUTI AP, 1994. Reduction of myocardial infarct size in rats by IRFI-048, a selective analogue of vitamin E. Free Rad Biol Med 16: 427-435.
6. CAMPO GM, CECCARELLI S, SQUADRITO F, ALTAVILLA D, DORIGOTTI L, CAPUTI AP, 1997. Raxofelast (IRFI 016): A new hydrophilic vitamin E-like antioxidant agent. Cardiovasc Drug Rev 15: 157-173.
7. CAPUTI AP, ROSSI F, CARNEY K, BREZENOFF HE, 1980. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J Pharmacol Exp Ther 215: 309-316.
8. CENTORE R, BIANCO T, CECCARELLI S, DORIGOTTI L, 1995. Pharmacokinetic profile of raxofelast, a novel anti-oxidant agent chemically related to alpha-tocopherol. Pharmacol Res 31 (Suppl. 2): 38.
9. CORONGIU F, LAI M, MILAI A, 1983. Carbon tetrachloride bromotrichlormethane and ethane acute intoxication. Biochem J 212: 625-631.
10. DIEDERICHS F, WITTENBERG H, SOMMERFELD U, 1990. Myocardial cell damage and breakdown of action homeostasis during conditions of ischaemia and reperfusion, the oxygen paradox, and reduced extracellular calcium. J Clin Chem Biochem 28: 139-148.
11. DREYER WJ, MICHAEL LH, WEST MS, SMITH CW, ROTHLEINR MK, ROSSEN RD, ANDERSON DC, ENTMAN ML, 1991. Neutrophil accumulation in ischemic canine myocardium. Insight into time course, distribution and mechanism of localization during early reperfusion. Circulation 84: 400-411.
12. ELLMAN GL, 1959. Tissue sulphydryl groups. Arch Biochem Biophys 82: 70-77.
13. FERRARI R, CECONI C, CURELLO S, GUARNIERI C, CALDARERA CM, ALBERTINI A, VISIOLI O, 1985. Oxygen-mediated myocardial damage during ischemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 17: 937-945.
14. GRANGER DN, KORTHUIS J, 1995. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 57: 311-332.
15. GRISWOLD DE, HILLEGASS LM, HILL DE, EGAN JW, SMITH EF III, 1988. Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue. J Pharmacol Methods 20: 225-235.
16. HALL ED, YONKERS PA, HORAN KL, 1989. Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U-Z4006F. Evidence for an in vivo antioxidant mechanism. J Neurotrauma 6: 169-176.
17. HALLIWELL B, 1990. How to characterize a biological antioxidant. Free Rad Res Commun 9: 1-32.
18. HAMMOND B, HESS ML, 1985. The oxygen free radical system: potential mediator of myocardial injury. J Am Coll Cardiol 6: 215-220.
19. HATORI N, MIYAZAKI A, TADOKOVO H, RYDEN L, MOLL J, RAJAGOPALAN RE, FISHBEIN MC, MEERBAUM S, CORDAY E, DRURY JK, 1989. Beneficial effects of coronary venous retroinfusion of superoxide dismutase and catalase on reperfusion arrhythmias, myocardial function and infarct size in dogs. J Cardiovasc Pharmacol 14: 396-403.
20. JENNINGS RB, REIMER KA, STEENBERGEN C, 1986. Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol 18: 769-780.
21. KLEIN HH, PUSHMANN SP, SCHAPER J, SCHAPER W, 1981. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Arch Pathol Anat 393: 287-297.
22. KLEIN HH, PICH S, LINDERT K, NEBENDAHL P, NIEDMANN P, KREUZER H, 1989. Combined treatment with vitamin E and C in experimental myocardial infarction in pigs. Am Heart J 118: 667-673.
23. KLEIN HH, PICH S, LINDERT K, NEBENDAHL K, NIEDMANN P, 1993. Failure of chronic, high dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. J Mol Cell Cardiol 25: 103-112.
24. KLONER R, PRZYKLENK K, WHITTAKEN P, 1989. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation 80: 1115-1127.
25. KLONER RA, GIACOMELLI F, ALKER KJ, HALE SL, MATTHEWS R, BELLOWS S, 1991. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 84: 1758-1772.
26. LEUNG H, VANG MJ, MAVIS RD, 1981. The cooperative interaction between vitamin E and vitamin C in suppression of peroxidation of membrane phospholipids. Biochem Biophys Acta 664: 266-272.
27. MASSEY KD, BURTON KP, 1989. Alpha-tocopherol attenuates myocardial membrane related alterations resulting from ischemia and reperfusion. Am J Physiol 256: 1192-1199.
28. MATTOLI S, MEZZETTI M, ALLEGRA L, BRAGA PC, 1991. Dihydro-Hydroxy-Trimethyl-Benzofuranyl acetic acid inhibits lipid peroxidation and lysosomal enzyme release in bronchial epithelial cells and macrophages. Ital J Chest Dis 45: 78-80.
29. MCCAY PB, 1985. Vitamin E: interactions with free radicals and ascorbate. Ann Rev Nutr 5: 323-340.
30. MULLANE KM, KRAEMER R, SMITH B, 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischaemic myocardium. J Pharmacol Meth 14: 157-167.
31. NIEREMBERG DW, LESTER DC, 1985. Determination of vitamins E and A in serum and plasma using a simplified clarification method and high-performance liquid chromatography. J Chromatogr 345: 275-284.
32. NIKI E, YAMAMOTO Y, KOMURO E, SATO E, 1991. Membrane damage due to lipid peroxidation. Am J Clin Nutr 53: 2015-2055.
33. RUBINSTEIN JD, LESNEFSKY EJ, BYLER RM, FENNESSEY PV, HORWITZ LD, 1992. Trolox C, a lipid-soluble membrane protective agent, attenuates myocardial injury from ischemia and reperfusion. Free Rad Biol Med 13: 627-634.
34. SAMAJA M, MOTTERLINI R, SANTORO F, DELL'ANTONIO G, CORNO A, 1994. Oxidative injury in reoxygenated and reperfused hearts. Free Rad Biol Med 16: 255-262.
35. SEEKAMP A, WARD PA, 1993. Ischemia-reperfusion injury [review]. Agents Actions 41: 137-152.
36. SHUM-TIM D, TCHERVENKOV CI, CHIU RC, 1992. Oral vitamin E prophylaxis in the protection of newborn myocardium from global ischemia. Surgery 112: 441-450.
37. SINGAL PK, DHALLA AK, HILL M, THOMAS PT, 1993. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem 129: 179-186.
38. SQUADRITO F, ALTAVILLA D, AMMENDOLIA L, SQUADRITO G, CAMPO GM, SPERANDEO A, CANALE P, IOCULANO M, SAITTA A, CAPUTI AP, 1995. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid U-74389G in splanchnic ischemia-reperfusion injury in the rat. Br J Pharmacol 115: 395-400.
39. STEARE SE, YELLON DM, 1995. The potential for endogenous myocardial antioxidants to protect the myocardium against ischemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach? J Mol Cell Cardiol 27: 65-74.
40. TANG XL, MCCAY PB, SUN JZ, HARTLEY CJ, SCHLEMAN M, BOLLI R, 1995. Inhibitory effect of a hydrophilic α-tocopherol analogue, MDL 74,405, on generation of free radicals in stunned myocardium in dogs. Free Rad Res 22: 293-302.
41. URSO R, MOLTONI L, BILLARELLI C, SEGRE G, 1992. Pharmacokinetics of IRFI 016 and IRFI 005 in rats. Pharmacol Res 26 (Suppl. 1): 265.
42. VANHAECKE J, FLAMENG W, BORGERS M, JANG IK, VAN DE WERF F, DE GEEST H, 1990. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 67: 1201-1210.
43. WANG QD, URUIDA Y, LI XS, NORDLANDER R, SJOQUIST PO, RYDEN L, 1995. Beneficial effects of H290/51, a new lipid peroxidation inhibitor, on functional recovery after ischemia and reperfusion in isolated cold-arrested rat hearts. J Cardiovasc Pharmacol 25: 924-929.
44. WEISEL RD, MICKLE DAG, FINKL CD, 1989. Myocardial free-radical injury after cardioplegia. Circulation 80 (Suppl. III): III-14-III-18.
45. WILLS ED, 1987. Evaluation of lipid peroxidation in lipid and biological membranes. In: Snell K and Mullock B (eds). Biochemical Toxicology; a practical approach. Oxford: IRL press, 127-152.